![Emily Anne Scraggs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emily Anne Scraggs
Director/Board Member at Talisman Therapeutics Ltd.
Emily Anne Scraggs active positions
Companies | Position | Start | End |
---|---|---|---|
Talisman Therapeutics Ltd.
![]() Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - | - |
Corporate Officer/Principal | - | - |
Career history of Emily Anne Scraggs
Former positions of Emily Anne Scraggs
Companies | Position | Start | End |
---|---|---|---|
Gen2 Neuroscience Ltd.
![]() Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Director/Board Member | 06/01/2016 | - |
Founder | 06/01/2016 | - |
Statistics
International
United Kingdom | 3 |
Operational
Director/Board Member | 2 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Gen2 Neuroscience Ltd.
![]() Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Talisman Therapeutics Ltd.
![]() Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Emily Anne Scraggs
- Experience